Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-CBX5 (Clone RAB-C133)
| Applications | ChIP, ELISA |
| Reactivities | Human |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
| Applications | FC, IF |
| Reactivities | Human |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
| Applications | FC, WB |
| Reactivities | Escherichia coli |
Anti-TIGIT [AET2010], Human IgG1, lambda
| Applications | ELISA, FC |
| Reactivities | Human |